8-K 1 a2082045z8-k.txt 8-K SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 JUNE 10, 2002 ------------------- Date of Report (Date of earliest event reported) ------------------- ESSENTIAL THERAPEUTICS, INC. --------------------- (Exact Name of Registrant as Specified in Charter) DELAWARE 0-28006 94-3186021 ------------------------------- ------------------ ---------------------------- (State or Other Jurisdiction of (Commission (IRS Employer Incorporation) File Number) Identification No.) 1365 MAIN STREET, WALTHAM, MA 02451 --------------------------------------------------- (Address of Principal Executive Offices) (Zip Code) (781) 647-5554 ---------------------------------------------------- (Registrant's telephone number, including area code) --------------- ITEM 5. OTHER EVENTS. On June 10, 2002, the Registrant issued a press release reporting its intention to advance clinical development programs and to restructure resources to focus on development goals. The press release has been filed as an exhibit to this Current Report on Form 8-K, attached hereto as Exhibit 99.1. ITEM 7. FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS. (c) Exhibits. EXHIBIT NUMBER DESCRIPTION 99.1 Press release, dated June 10, 2002. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: June 10, 2002 ESSENTIAL THERAPEUTICS, INC. By: /s/ Paul J. Mellett ------------------------------------------ Paul J. Mellett, Senior Vice President, Chief Financial Officer and Treasurer (Principal Financial Officer)